Reporte zur Charge UJ386AA/U6627AB

Symptomtext

if they need to revaccinate a patient who was given YF-VAX vaccine with expired diluent with no reported adverse event; Initial information receivedon 25-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and gender patient who was given yf-vax vaccine with expired diluent with no reported adverse event while receiving vaccine YELLOW FEVER VACCINE [YF-VAX]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE (Lot: UJ386AA Expiration: 22Aug2022 Diluent: Lot: U6627AB Expiration: 20May2022) once at an unknown dose via unknown route at an unknown administration site for immunization. On an unknown date ,the patient was given yf-vax vaccine with expired diluent with no reported adverse event (expired product administered) (latency: same day) following the administration of YELLOW FEVER VACCINE. Action taken : not applicable It was not reported if the patient received a corrective treatment for the event. Outcome:Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.